COVID control measures' impact on U.S. companies in China 2022

Published by
Wenyi Zhang,
Jan 27, 2023
In a survey among U.S. companies operating in China conducted in June 2022, about 96 percent of respondents stated that their businesses in China were either severely or moderately impacted by the country's strict COVID-19 control measures. Only four percent of all companies surveyed reported negligible impacts of the Zero-COVID policy on their operations.

Impacts of COVID-19 control measures on U.S. companies operating in China as of June 2022

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2022

Region

China, United States

Survey time period

June 2022

Special properties

among 117 member US companies operating in China

Supplementary notes

The industry distribution of the surveyed companies is as follows:
39% in the manufacturing industry, 39% in the service industry, 24% in the tech-intensity industry, 10% in the energy sector, 4% in the agriculture sector, and 11% in others.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus (COVID-19) in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19) in China

Overview

6

Healthcare system in China

5

Vaccination

7

Impact on economy and society

8

Impact on foreign companies and investors

6

Further Content: You might find this interesting as well

Topics

Coronavirus COVID-19 in ChinaDiabetes in ChinaPharmaceutical industry in ChinaVaccine industry in ChinaFitness industry in China
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu